Lumexa Imaging Holdings, Inc. Common Stock
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
lmri · stock forecast · 2 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Strong Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$23.00
Consensus
$20.57
+150.2% upside
Low
$9.00
Median: $22 · Last Close: $8.22
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$20.57
150.2% upside
High Target
$23
179.8%
Low Target
$9
9.5%
Current Price
$8.22
as of today
Based on analyst price targets, the LMRI stock price prediction for the next 12 months ranges from $9 to $23. The consensus LMRI price forecast of $20.57 implies 150.2% upside from the current price of $8.22.
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.27 | ↑ 0.59% |
1-day model range: $8.15–$8.39. Peak: $8.39 (+0.59%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LMRI · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-20 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-14 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-09 | Raymond James | Upgrade ↑ | Outperform→Strong Buy |
Wall Street analysts have recently issued updated ratings on Lumexa Imaging Holdings, Inc. Common Stock (LMRI) stock. Of the recent 3 rating actions, 1 were upgrades and 0 were downgrades. 2 analysts currently cover LMRI.
Analyst Recommendation Trends
LMRI analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1.1B
↓ 10.1% YoY
Revenue Next Year
$1.1B
↑ 5.5% YoY
EPS This Year
$0.75
EPS Next Year
$0.85
↑ 12.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast LMRI EPS of $0.75 for the current fiscal year, based on estimates from 3 analysts. The LMRI revenue forecast is $1.1B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LMRI stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LMRI price target is $20.57 (+150.2% upside), with an analyst consensus of Strong Buy.
The LMRI short-term stock prediction for tomorrow is $8.27 (+0.59%).
Lumexa Imaging Holdings, Inc. Common Stock trades on NASDAQ under the ticker LMRI. The LMRI stock outlook for 2027 is broadly positive, supported by a Strong Buy consensus among 100% of covering analysts.
Frequently asked questions
LMRI forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month LMRI price target is $20.57, with a high forecast of $23.00 and a low of $9.00. The median price target is shown in the chart above when available. This implies +150.2% potential upside from the current price of $8.22.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.